União Europeia - português - EMA (European Medicines Agency)

nanotherapeutics bohumil, s.r.o. - whole virion influenza vaccine, inactivated containing antigen of strain a/california/07/2009 (h1n1)v - disease outbreaks; influenza, human; immunization - vacinas - profilaxia da gripe causada pelo vírus a (h1n1) v 2009. celvapan deve ser usado de acordo com orientação oficial.

Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

zenimport comercio importacao e exportacao ltda - fitoterapico simples

Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

laboratoire pharmaceutique pharmatoka - n/a - cápsula - 195.7 - 216.9 mg - extrato seco e refinado do sumo do fruto de vaccinium macrocarpon aiton, der 250:1, solvente: etanol 70% (v/v) 195.7 mg - other urologicals - tradicional à base de plantas - duração do tratamento: curta ou média duração

Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

laboratoire pharmaceutique pharmatoka - n/a - cápsula - 195.7 - 216.9 mg - extrato seco e refinado do sumo do fruto de vaccinium macrocarpon aiton, der 250:1, solvente: etanol 70% (v/v) 195.7 mg - other urologicals - tradicional à base de plantas - duração do tratamento: curta ou média duração

Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

laboratoire pharmaceutique pharmatoka - n/a - cápsula - 195.7 - 216.9 mg - extrato seco e refinado do sumo do fruto de vaccinium macrocarpon aiton, der 250:1, solvente: etanol 70% (v/v) 195.7 mg - other urologicals - tradicional à base de plantas - duração do tratamento: curta ou média duração

Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

laboratoire pharmaceutique pharmatoka - n/a - cápsula - 195.7 - 216.9 mg - extrato seco e refinado do sumo do fruto de vaccinium macrocarpon aiton, der 250:1, solvente: etanol 70% (v/v) 195.7 mg - other urologicals - tradicional à base de plantas - duração do tratamento: curta ou média duração

União Europeia - português - EMA (European Medicines Agency)

novartis europharm limited - eltrombopag - purpura, trombocitopénica, idiopática - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 e 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 e 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.

União Europeia - português - EMA (European Medicines Agency)

novartis europharm limited - crizanlizumab - anemia, célula falciforme - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.

União Europeia - português - EMA (European Medicines Agency)

pfizer europe ma eeig  - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.

Portugal - português - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

omedicamed, unipessoal lda - lisados polibacterianos - cápsula - 7 mg - klebsiella ozaenae klebsiella ozaenae ; moraxella (branhammella) catarrhalis moraxella (branhammella) catarrhalis ; staphylococcus aureus staphylococcus aureus ; streptococcus pyogenes streptococcus pyogenes ; klebsiella pneumoniae klebsiella pneumoniae ; streptococcus sanguinis streptococcus sanguinis ; haemophilus influenzae haemophilus influenzae ; streptococcus pneumoniae streptococcus pneumoniae - other respiratory system products - vacina - duração do tratamento: curta ou média duração